Cat. No. | Product Name | Field of Application | Chemical Structure |
---|---|---|---|
DC10796 | Prexasertib (LY2606368) Featured |
LY2606368 is a potent and selective ATP competitive inhibitor(IC50=1.5 nM in SW1990 cell) of the Chk1 protein kinase.
More description
|
![]() |
DC74584 | LY2880070 |
LY2880070 is an orally active inhibitor of CHK1. LY2880070 can be used as an anticancer agent and shows promise in preclinical models of pancreatic ductal adenocarcinoma (PDAC) when used in combination with DNA-damaging agents.
More description
|
![]() |
DC7076 | AZD-7762 Featured |
AZD7762 is a potent and selective inhibitor of Chk1 with IC50 of 5 nM; equally potent against Chk2 and less potent against CAM, Yes, Fyn, Lyn, Hck and Lck.
More description
|
![]() |
DC5024 | MK-8776 (SCH 900776) Featured |
SCH 900776 is a selective Chk1 inhibitor with IC50 of 3 nM. It shows 50-fold selectivity against Chk2. Phase 2.
More description
|
![]() |
DC7993 | Prexasertib (LY2606368) 2HCl Featured |
LY2606368 2Hcl is a potent and selective ATP competitive inhibitor(IC50=1.5 nM in SW1990 cell) of the Chk1 protein kinase.
More description
|
![]() |
DC7103 | LY2603618(IC-83) Featured |
LY2603618(IC-83) is a potent and selective small molecule inhibitor of Chk1 protein kinase activity in vitro (IC50=7 nM) and the first selective Chk1 inhibitor to enter clinical cancer trials.
More description
|
![]() |
DC9792 | SAR020106 Featured |
SAR-020106 is an ATP-competitive, potent, and selective CHK1 inhibitor with an IC(50) of 13.3 nmol/L on the isolated human enzyme.
More description
|
![]() |
DC8259 | PF0477736 Featured |
PF 477736 is a CHK inhitor with Ki values of 0.49 and 47 nM for Chk1 and Chk2 respectively. A proprietary compound targeting cell cycle checkpoint kinase 1 (chk1) with potential chemopotentiation activity
More description
|
![]() |
DC8324 | CCT244747 Featured |
CCT244747 represents the first structural disclosure of a highly selective, orally active CHK1 inhibitor and warrants further evaluation alone or combined with genotoxic anticancer therapies.
More description
|
![]() |
DC48120 | Chk1-IN-6 |
Chk1-IN-6 is a potent, selective, and orally bioavailable CHK1 inhibitor candidate.
More description
|
![]() |
DC10485 | GDC0575(ARRY-575,RG7441) Featured |
GDC0575(ARRY-575,RG7441)is a small molecule inhibitor of cell cycle checkpoint kinase 1 (Chk1), with potential chemosensitization activity.
More description
|
![]() |
DC41105 | Prexasertib dimesylate |
Prexasertib dimesylate (LY2606368 dimesylate) is a selective, ATP-competitive second-generation checkpoint kinase 1 (CHK1) inhibitor with a Ki of 0.9 nM and an IC50 of <1 nM. Prexasertib dimesylate inhibits CHK2 (IC50=8 nM) and RSK1 (IC50=9 nM). Prexasertib dimesylate causes double-stranded DNA breakage and replication catastrophe resulting in apoptosis. Prexasertib dimesylate shows potent anti-tumor activity.
More description
|
![]() |
DC41104 | Prexasertib Mesylate Hydrate |
Prexasertib Mesylate Hydrate (LY2606368 Mesylate Hydrate) is a selective, ATP-competitive second-generation checkpoint kinase 1 (CHK1) inhibitor with a Ki of 0.9 nM and an IC50 of <1 nM. Prexasertib Mesylate Hydrate inhibits CHK2 (IC50=8 nM) and RSK1 (IC50=9 nM). Prexasertib Mesylate Hydrate causes double-stranded DNA breakage and replication catastrophe resulting in apoptosis. Prexasertib Mesylate Hydrate shows potent anti-tumor activity.
More description
|
![]() |
DC40569 | Chk1-IN-5 |
Chk1-IN-5 is a potent checkpoint kinase 1 (Chk1) inhibitor. Chk1-IN-5 inhibits Chk1 phosphorylation and inhibits tumor growth in colon cancer xenograft model.
More description
|
![]() |
DC9924 | SB218078 Featured |
SB218078 is an inhibitor of checkpoint kinase 1 (Chk1) that displays selectivity over other protein kinases (IC50 values are 15, 250 and 1000 nM for Chk1, cdc2 and PKC respectively).
More description
|
![]() |
DC11732 | GNE-900 |
GNE-900 (GNE900) is a potent, selective, ATP-competitive, and orally bioavailable Chk1 inhibitor with IC50 of <1 nM.
More description
|
![]() |
DC9399 | CCT241533 (hydrochloride) |
CCT241533 Hcl is a potent serine/threonine checkpoint kinase (Chk2) inhibitor with IC50 of 3 nM; shows minimal cross-reactivity against a panel of kinases at 1 uM.
More description
|
![]() |
DC11716 | XL-844 |
A potent, specific, orally available, ATP‑competitive inhibitor of Chk1 and Chk2 with Ki of 2.2 nM and 0.07 nM, respectively.
More description
|
![]() |
DC11713 | NSC-109555 ditosylate |
A potent, selective, reversible, ATP-competitive Chk2 inhibitor with IC50 of 0.2 uM.
More description
|
![]() |
DC11733 | SAR-020106 |
A potent, selective, ATP-competitive Chk1 inhibitor with IC50 of 13.3 nM.
More description
|
![]() |
DC11711 | VER-158411 |
A potent, selective, ATP-competitive Chk1 and Chk2 inhibitor with IC50 of 4.4 nM and 4.5 nM, respectively.
More description
|
![]() |
DC11710 | GDC-0425 |
A potent, selective and orally active Chk1 inhibitor.
More description
|
![]() |
DC11717 | PD-321852 |
A potent, reasonably selective Chk1 inhibitor with cell IC50 of 5 nM.
More description
|
![]() |
DC11714 | PV-1019 |
A potent, ATP-competitive and highly selective Chk2 inhibitor with IC50 of 138 nM.
More description
|
![]() |
DC11654 | VRX-0466617 |
A potent and selective Chk2 inhibitor with Ki/IC50 of 11 nM/120 nM.
More description
|
![]() |
DC11715 | PV-1115 |
A potent and highly selective Chk2 inhibitor with IC50 of 0.14 nM.
More description
|
![]() |
DC11953 | MU 380 |
A novel potent, selective CHK1 inhibitor 2 nM, >80-fold selectivity over CHK2.
More description
|
![]() |
DC11718 | Debromohymenialdisine |
A marine sponge alkaloid that inhibits Chk1 and Chk2 with IC50 of 3 and 3.5 uM, respectively.
More description
|
![]() |